Title |
Genome‐wide association study in German patients with attention deficit/hyperactivity disorder
|
---|---|
Published in |
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics: The Official Publication of the International Society of Psychiatric Genetics, October 2011
|
DOI | 10.1002/ajmg.b.31246 |
Pubmed ID | |
Authors |
Anke Hinney, André Scherag, Ivonne Jarick, Özgür Albayrak, Carolin Pütter, Sonali Pechlivanis, Maria R. Dauvermann, Sebastian Beck, Heike Weber, Susann Scherag, Trang T. Nguyen, Anna‐Lena Volckmar, Nadja Knoll, Stephen V. Faraone, Benjamin M. Neale, Barbara Franke, Sven Cichon, Per Hoffmann, Markus M. Nöthen, Stefan Schreiber, Karl‐Heinz Jöckel, H.‐Erich Wichmann, Christine Freitag, Thomas Lempp, Jobst Meyer, Susanne Gilsbach, Beate Herpertz‐Dahlmann, Judith Sinzig, Gerd Lehmkuhl, Tobias J. Renner, Andreas Warnke, Marcel Romanos, Klaus‐Peter Lesch, Andreas Reif, Benno G. Schimmelmann, Johannes Hebebrand, Psychiatric GWAS Consortium: ADHD subgroup |
Abstract |
The heritability of attention deficit hyperactivity disorder (ADHD) is approximately 0.8. Despite several larger scale attempts, genome-wide association studies (GWAS) have not led to the identification of significant results. We performed a GWAS based on 495 German young patients with ADHD (according to DSM-IV criteria; Human660W-Quadv1; Illumina, San Diego, CA) and on 1,300 population-based adult controls (HumanHap550v3; Illumina). Some genes neighboring the single nucleotide polymorphisms (SNPs) with the lowest P-values (best P-value: 8.38 × 10(-7)) have potential relevance for ADHD (e.g., glutamate receptor, metabotropic 5 gene, GRM5). After quality control, the 30 independent SNPs with the lowest P-values (P-values ≤ 7.57 × 10(-5) ) were chosen for confirmation. Genotyping of these SNPs in up to 320 independent German families comprising at least one child with ADHD revealed directionally consistent effect-size point estimates for 19 (10 not consistent) of the SNPs. In silico analyses of the 30 SNPs in the largest meta-analysis so far (2,064 trios, 896 cases, and 2,455 controls) revealed directionally consistent effect-size point estimates for 16 SNPs (11 not consistent). None of the combined analyses revealed a genome-wide significant result. SNPs in previously described autosomal candidate genes did not show significantly lower P-values compared to SNPs within random sets of genes of the same size. We did not find genome-wide significant results in a GWAS of German children with ADHD compared to controls. The second best SNP is located in an intron of GRM5, a gene located within a recently described region with an infrequent copy number variation in patients with ADHD. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 3 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 2 | 2% |
United States | 2 | 2% |
Unknown | 124 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 26 | 20% |
Researcher | 25 | 20% |
Student > Master | 13 | 10% |
Student > Doctoral Student | 11 | 9% |
Professor | 8 | 6% |
Other | 22 | 17% |
Unknown | 23 | 18% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 28 | 22% |
Agricultural and Biological Sciences | 26 | 20% |
Psychology | 19 | 15% |
Biochemistry, Genetics and Molecular Biology | 10 | 8% |
Neuroscience | 7 | 5% |
Other | 13 | 10% |
Unknown | 25 | 20% |